Related Experiment Video
Updated: Oct 20, 2025
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Decrease in Cell Viability of Breast Cancer Cells by a Di-Hydroxylated Derivative of
Norma L Galindo-Alvarez1, Humberto L Mendoza-Figueroa1, Martha C Rosales-Hernández2
1Laboratorio de Diseño y Desarrollo de Nuevos Fármacos e Innovación Biotecnológica (Laboratory for the Design and Development of New Drugs and Biotechnological Innovation), Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Salvador Díaz Mirón s/n, Casco de Santo Tomás, Ciudad de México 11340, México.
The di-hydroxylated derivative N-(2,5-dihydroxyphenyl)-2-propylpentanamide (5b) shows enhanced anti-proliferative effects in breast cancer cells. This activity may be linked to its inhibition of HDAC1, suggesting potential for new breast cancer therapies.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Enzyme Inhibition
Background:
- Cytochrome P450 enzymes (CYP) biotransformed N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA), an HDAC inhibitor.
- Two hydroxylated derivatives, N-(2,4-dihydroxyphenyl)-2-propylpentanamide (5a) and N-(2,5-dihydroxyphenyl)-2-propylpentanamide (5b), were synthesized.
Purpose of the Study:
- To evaluate the anti-proliferative activity of di-hydroxylated derivatives (5a and 5b) in breast cancer cell lines.
- To investigate the in silico affinity of these derivatives with the HDAC1 enzyme.
Main Methods:
- MTT assays were performed on MCF-7 and MDA-MB-231 breast cancer cell lines.
- In silico docking studies were conducted to assess the binding affinity with HDAC1.
Main Results:
- Compound 5b demonstrated enhanced anti-proliferative effects against both MCF-7 and MDA-MB-231 cell lines.
- Docking studies indicated that hydroxyl group position impacts HDAC1 affinity, potentially explaining the reduced activity of compound 5a.
Conclusions:
- The anti-proliferative activity of compound 5b in breast cancer cells is hypothesized to be related to HDAC1 inhibition.
- These findings suggest that derivative 5b holds potential for further development as an anti-cancer agent targeting HDAC1.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015